Toimeentulotuen saajien lääkekorvausoikeudet ja lääkkeiden käyttö

Aaltonen, Katri; Lekander, Kaarlo; Ahola, Elina; Hiilamo, Heikki

doi:10.23990/sa.68862

Cited by 3 publications

(4 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Recent migrants may have particular barriers in accessing services. In Finland, migrants less often apply for special reimbursement than Finnish-born people (Aaltonen, Lekander, Ahola, & Hiilamo, 2018). It is possible that not all migrants are aware that people with a psychotic disorder are entitled to full reimbursement for antipsychotic medication or they have problems applying it.…”

Section: Discussionmentioning

confidence: 99%

Continuity of antipsychotic medication use among migrant and Finnish-born populations with a psychotic disorder: a register-based study

Lehti

Taipale²,

Gissler³

et al. 2021

Psychol. Med.

View full text Add to dashboard Cite

Background Higher incidence of psychotic disorders and underuse of mental health services have been reported among many migrant populations. This study examines the initiation and continuity of antipsychotic treatment among migrants and non-migrants with a non-affective psychosis during a new treatment episode. Methods This study is based on a nationwide sample of migrants and Finnish-born controls. Participants who were diagnosed with a psychotic disorder in 2011–2014 were identified from the Care Register for Health Care (n = 1693). Information on purchases of antipsychotic drugs in 2011–2015 was collected from the National Prescription Register. The duration of antipsychotic treatment since diagnosis was estimated using the PRE2DUP model. Cox regression analysis was used to study factors that are associated with discontinuing the use of medication. Results There were fewer initiators of antipsychotic treatment after being diagnosed with psychosis among migrants (68.1%) than among Finnish-born patients (73.6%). After controlling for sociodemographic background and factors related to the type of disorder and treatment, migrants were more likely to discontinue medication (adjusted hazard ratio 1.28, 95% confidence interval 1.08–1.52). The risk of discontinuation was highest among migrants from North Africa and the Middle East and Sub-Saharan Africa and among recent migrants. Non-use of antipsychotic treatment before being diagnosed with psychosis, involuntary hospitalization and diagnosis other than schizophrenia were associated with earlier discontinuation both among migrants and non-migrants. Conclusions Migrants with a psychotic disorder are less likely to continue antipsychotic treatment than non-migrants. The needs of migrant patients have to be addressed to improve adherence.

show abstract

Section: Discussionmentioning

confidence: 99%

Continuity of antipsychotic medication use among migrant and Finnish-born populations with a psychotic disorder: a register-based study

Lehti

Taipale²,

Gissler³

et al. 2021

Psychol. Med.

View full text Add to dashboard Cite

show abstract

“…There is evidence of more expensive medicines being prescribed in the private sector compared with the public sector (Aaltonen et al . 2018). The lower use of above‐mentioned medicines may indicate a higher use of public services; people with ID generally require specialised medical care, which is a public service in Finland.…”

Section: Discussionmentioning

confidence: 99%

“…It is noteworthy that the medicines that were less used among people with ID, the angiotensin II receptor blockers (C09C, D) are more expensive than other cardiovascular medicines, and antineoplastic agents are considerably expensive. There is evidence of more expensive medicines being prescribed in the private sector compared with the public sector (Aaltonen et al 2018). The lower use of above-mentioned medicines may indicate a higher use of public services; people with ID generally require specialised medical care, which is a public service in Finland.…”

Section: Discussionmentioning

confidence: 99%

Medicine use in people with intellectual disabilities: a Finnish nationwide register study

Nurminen

Rättö

Arvio

et al. 2022

J intellect Disabil Res

View full text Add to dashboard Cite

Background People with intellectual disability (ID) are a vulnerable group in our society; many of them depend on other people for assistance in their everyday lives. Compared with the general population, people with ID have poorer general health and, therefore, need more healthcare services and use more medicines. The aim of this study is to define the population of all Finnish people with ID using administrative data and to compare their medicine use and expenditure on medicines to those of the age-matched and sex-matched controls. Methods People with ID and their age-matched and sex-matched controls (1:1) were extracted from nationwide healthcare and social allowance registers. Administrative register data on all prescription medicine purchases in 2019 were used to determine the prevalence of medicine use in both groups on a general level and by medicine categories. The differences in the prevalence of medicine use between the two groups were analysed using the logistic regression model. In addition, we studied the total expenditure on reimbursable medicine purchases covered by the National Health Insurance between people with ID and control group. ResultsThe subpopulation of people with ID consisted 37 196 individuals, of whom 82.7% purchased prescription medicines in 2019. The corresponding share of individuals purchasing prescription medicines in the control group was 70.3%. The differences in the prevalence of medicine use between the two populations were highest in the younger age groups (0-6, 7-12 and 13-17). In the study population, 28.1% (OR = 12.28; 95% CI: 11.54-13.07) of the people used antipsychotics, making it the most used medicine category in people with ID. In the control group, 3.3% of people used antipsychotics. Compared with the control group, the use of antiepileptics, drugs for constipation, mineral supplements and anxiolytics was four to seven times higher among people with ID. Furthermore, the median expenditure on medicine use among people with ID was four times higher than in the control group. Conclusions Compared with the control group, people with ID used more medicines, especially

show abstract

“…While intended as a short-term last-resort relief to overcome temporary economic difficulties, social assistance periods are not typically short, with an average of 6 months (19). Some 70 percent of people receiving social assistance are unemployed and only five percent of social assistance recipients have some income from employment (20).…”

Section: Outcomementioning

confidence: 99%

The contribution of parental health to the subsequent social assistance entry of the family with children– a nationwide register-linked birth cohort study in Finland

Hiilamo¹,

Keski‐Säntti

Räsänen

et al. 2023

Preprint

View full text Add to dashboard Cite

Aim Our aim in this paper is to quantify the contribution of different parental specialised health care diagnoses to the subsequent risk of entry into the social assistance system for families with children. Methods We used longitudinal population level register data consisting of all children born in 1997 in Finland and their registered parents (54 960 one and two parent families with 801 336 observations in the period 1998 2013). All diagnoses assigned in public specialised health care (ICD 10) and social assistance use records were derived from nationwide administrative registers. Measures of parental socioeconomic status and previous diagnoses and the birth weight of the child were adjusted for in regression models which estimated the association between parental diagnoses and entry into the social assistance system in the following year. Risk ratios and population attributable fractions were calculated. Results Families with a parent somatic diagnosis had a risk ratio of 1.3 for social assistance entry in the subsequent year of the diagnosis though substantial variation by diagnosis category was also detected. Parent psychiatric diagnoses were linked to a higher, 3.01-fold risk of social assistance entry. Covariate adjustment reduced these risk ratios to 1.2 and 2.3, respectively. Some 2.9 percent of all social assistance entries may be attributed to parental psychiatric diagnoses while somatic health records account for another 7.2 percent. Conclusion Parental specialised health care records can be linked to a substantially higher risk of social assistance need as more interventions to support financial management are required for parents with psychiatric diagnoses.

show abstract

Toimeentulotuen saajien lääkekorvausoikeudet ja lääkkeiden käyttö

Cited by 3 publications

References 5 publications

Continuity of antipsychotic medication use among migrant and Finnish-born populations with a psychotic disorder: a register-based study

Continuity of antipsychotic medication use among migrant and Finnish-born populations with a psychotic disorder: a register-based study

Medicine use in people with intellectual disabilities: a Finnish nationwide register study

The contribution of parental health to the subsequent social assistance entry of the family with children– a nationwide register-linked birth cohort study in Finland

Contact Info

Product

Resources

About